IM
Ivana Magovcevic-Liebisch
President and CEO

Ivana Magovcevic-Liebisch insider trades: Vigil Neuroscience (VIGL) stock buys and sales

President and CEO, Vigil Neuroscience Last trade Dec 19, 2024 58 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2008
7
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ivana reports to the SEC

and 1 more company

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 19, 2024VIGL↑ Buy$8K
Dec 18, 2024VIGL↑ Buy$8K
Dec 5, 2024VIGL↑ Buy$12K
Nov 20, 2023VIGL↑ Buy$15K
May 3, 2022VIGL↑ Buy$18K
Nov 16, 2016AGTC↑ Buy$29K
Mar 6, 2013DYAX↓ Sell$861K
Feb 25, 2013DYAX↓ Sell$13K
Mar 16, 2011DYAX↑ Buy$8K
Jun 25, 2010DYAX↓ Sell$31K
May 26, 2010DYAX↓ Sell$34K
May 19, 2010DYAX↓ Sell$11K
Apr 2, 2008DYAX↓ Sell$30K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ivana Magovcevic-Liebisch's insider trades

Ivana Magovcevic-Liebisch is President and CEO at Vigil Neuroscience (VIGL). Since Apr 2, 2008, Ivana has reported 7 open-market purchases worth $98K and 6 sales worth $980K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (43 filings), option exercises (4 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VIGL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.